Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.

Pinheiro SP, Tworoger SS, Cramer DW, Rosner BA, Hankinson SE.

Am J Epidemiol. 2009 Jun 1;169(11):1378-87. doi: 10.1093/aje/kwp062. Epub 2009 Apr 2.

2.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.

Nagle CM, Ibiebele TI, DeFazio A, Protani MM, Webb PM; Australian Ovarian Cancer Study Group.

Cancer Epidemiol. 2015 Apr;39(2):196-9. doi: 10.1016/j.canep.2014.12.010. Epub 2015 Feb 7.

PMID:
25666512
3.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N; Ovarian Cancer Association Consortium.

J Natl Cancer Inst. 2014 Feb;106(2):djt431. doi: 10.1093/jnci/djt431.

4.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

5.

Aspirin, other NSAIDs, and ovarian cancer risk (United States).

Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE.

Cancer Causes Control. 2002 Aug;13(6):535-42.

PMID:
12195643
6.
7.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

PMID:
15928301
8.

Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.

Genkinger JM, De Vivo I, Stampfer MJ, Giovannucci E, Michaud DS.

Int J Cancer. 2007 May 15;120(10):2221-5.

9.
10.

Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.

Murphy MA, Trabert B, Yang HP, Park Y, Brinton LA, Hartge P, Sherman ME, Hollenbeck A, Wentzensen N.

Cancer Causes Control. 2012 Nov;23(11):1839-52. doi: 10.1007/s10552-012-0063-2. Epub 2012 Sep 13. Review.

11.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

12.

Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding.

Strate LL, Liu YL, Huang ES, Giovannucci EL, Chan AT.

Gastroenterology. 2011 May;140(5):1427-33. doi: 10.1053/j.gastro.2011.02.004. Epub 2011 Feb 12.

13.

Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study.

Prizment AE, Folsom AR, Anderson KE.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):435-42. doi: 10.1158/1055-9965.EPI-09-0976.

14.

Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.

Daugherty SE, Pfeiffer RM, Sigurdson AJ, Hayes RB, Leitzmann M, Schatzkin A, Hollenbeck AR, Silverman DT.

Am J Epidemiol. 2011 Apr 1;173(7):721-30. doi: 10.1093/aje/kwq437. Epub 2011 Mar 2. Review.

15.

Nonnarcotic analgesic use and the risk of hypertension in US women.

Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC.

Hypertension. 2002 Nov;40(5):604-8; discussion 601-3.

16.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.

Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB.

Epidemiology. 2012 Mar;23(2):311-9. doi: 10.1097/EDE.0b013e3182456ad3.

17.

Aspirin and other nonsteroidal anti-inflammatory drugs and risk of non-hodgkin lymphoma.

Teras LR, Gapstur SM, Patel AV, Thun MJ, Diver WR, Zhai Y, Jacobs EJ.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):422-8. doi: 10.1158/1055-9965.EPI-12-1158. Epub 2013 Jan 17.

18.

Medication use and risk of ovarian carcinoma: a prospective study.

Lacey JV Jr, Sherman ME, Hartge P, Schatzkin A, Schairer C.

Int J Cancer. 2004 Jan 10;108(2):281-6.

19.

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.

Breast Cancer Res. 2008;10(2):R38. doi: 10.1186/bcr2089. Epub 2008 Apr 30.

20.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

PMID:
15998950

Supplemental Content

Support Center